Aphria: Canaccord Anticipates Q2 2021 Revenue Of $156.3 Million

Aphria Inc (TSX: APHA) (NASDAQ: APHA) will be releasing their second-quarter fiscal 2021 financial results this week on January 14th before market open.

Currently, Aphria has 11 analysts covering the company with a weighted 12-month price target of C$10.85. This is up from the average at the start of the month, which was C$9.96. Two analysts have strong buys, while another six have buy ratings, and three analysts have hold ratings.

Canaccord has released their quarterly earnings preview for the firm. In the note, they maintained their C$11 12-month price target and hold rating on the company. Matt Bottomley headlines, “Expecting APHA to print incremental improvements and maintain leading Cdn position.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Canaccord expects total revenue to come in at C$156.3 million and EBITDA to be C$13.3 million for the second quarter. Bottomley expects this quarter to be a rebound from their miss in expectations for the first quarter. He writes, “However, for the quarter, we expect the company to see continued growth in its Cdn penetration as the company looks to maintain its #1 market position in the Cdn recreational market.” He believes that the Tilray merger and the acquisition of SweetWater will likely be the talking points for management during the conference call.

Bottomley expects recreational revenue to come in at C$76.9 million, or a 7.3% increase quarter over quarter. Aphria currently holds the #1 market share in the recreational space.

In terms of medical revenues, Bottomley comments, “seemingly fewer patients [are] booking appointments to renew their prescriptions on the back of COVID-19.” Canaccord as a result has forecasted that medical cannabis revenue will decline 5% to C$7.5 million, as their expectation is that the medical market has not grown but rather gone stagnate.

Aphria’s largest segment is expected to be hit the hardest this quarter. Bottomley expects a 17% drop quarter over quarter due to COVID headwinds, which include a reduction in the number of elective medical procedures and fewer visits to physicians/pharmacies by patients. They are forecasting C$92.1 million in revenue for this segment.

Bottomley expects that gross margins will remain strong during this quarter, at 28.2% or C$44.1 million. He expects adjusted EBITDA to come in at C$13.3 million as the company realizes higher operating leverage. He adds, “we believe Aphria will remain one of the only profitable LPs among market share leaders in Canada at this time.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Equinox Gold: The Analyst First Impression Of The Premier Gold Mines Transaction

Earlier this week, Equinox Gold Corp (TSX: EQX) announced the acquisition of Premier Gold Mines...

Saturday, December 19, 2020, 01:39:00 PM

Tesla: Canaccord Doubles Price Target To $1,071

On Monday, one of the more bearish Tesla Inc. (NASDAQ: TSLA) analysts flipped bullish, and...

Tuesday, April 13, 2021, 11:41:00 AM

Canopy Growth: Cowen & Co Slashes Price Target To $16

On November 5th, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second quarter...

Thursday, November 11, 2021, 04:50:00 PM

Dollar Tree: BMO Gets Bullish After Recent Operational Changes

Las tweek, BMO Capital Markets upgraded Dollar Tree (NASDAQ: DLTR) to outperform from market perform...

Sunday, March 6, 2022, 01:10:00 PM

BMO Initiates Coverage On Plug Power, Gives $30 Price Target

On September 30, BMO initiated coverage on Plug Power (NASDAQ: PLUG) with a $30 price...

Sunday, October 3, 2021, 05:10:00 PM